Enhancing supraspinal plasticity to improve functional recovery after SCI
Enhancing supraspinal plasticity to improve functional recovery after SCI
批准号:
9193741
负责人:
John Roland Bethea
金额:
$60.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2017-05-31
关键词:
AddressAnimal ExperimentsAnimalsAstrocytesAttenuatedAxonBehavioralBrainBrain StemBrain regionChronicCollaborationsCombined Modality TherapyContusionsDataDevelopmentElectric StimulationElectrophysiology (science)EquilibriumEventExerciseFiberGene ProteinsGliosisGoalsInflammationInterventionLesionLettersMeasuresMicrogliaMotorMovementNeuraxisNeurogliaNeuronal PlasticityNeuronsPatternPharmacotherapyPilot ProjectsPublishingRecoveryRecovery of FunctionReplacement TherapySelf-Help DevicesSensorySeriesSerotoninSideSourceSpinalSpinal cord injurySystemTNF geneTherapeuticTherapeutic InterventionThoracic spinal cord structureTimeTrainingTranslational ResearchWeightWorkastrogliosisbasebehavioral outcomebrain machine interfaceenhancing factorexoskeletonexperiencefunctional outcomesimprovedinsightnovelnovel therapeutic interventionpainful neuropathyrelating to nervous systemresearch studyresponsetherapy developmenttreadmill training
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
It is becoming increasingly evident that plasticity within supraspinal networks, induced by therapeutic
interventions, is necessary for optimal recovery of function after spinal cord injury. We have developed a novel
combination therapy of motorized bike, 5-HT replacement therapy and treadmill training that can restore
open-field weight-supported stepping (BBB score >9) in animals with complete spinal transection. Our
preliminary data suggest that both supraspinal neuronal and glial plasticity modulated by therapy and that
they influence each other. The central hypothesis of this proposal is that therapy combined with
strategies to either promote beneficial neural/glial plasticity and/or attenuate deleterious plasticity (e.g.,
astrogliosis and inflammation) will enhance supraspinal remodeling and improve functional outcome. This Aim
will be addressed with two Specific Aims. Aim 1: Investigate the impact of therapy on functional recovery and
supraspinal plasticity after SCI as measured by changes in neurons and glial cells and their relationship to
functional recovery. Aim 2: Determine if combining NCTherapy with: (A) strategies to enhance supraspinal
plasticity (e.g. via brain-machine interface (BMI) training) and/or (B) inhibiting aspects of reactive gliosis (e.g.
modulate TNF activity) is more effective than NCTherapy alone in improving functional recovery after SCI. The
results of this work will aid in the development of therapies for recovery of volitional control of movement.
Moreover, results could be used for translational research to develop assistive devices to maintain balance
(e.g. cortical control of an exoskeleton or functional electrical stimulation). Glial plasticity is defined as a
change in the number and or “activation” of astrocytes and microglia in response to SCI or therapy after SCI.
Neuronal plasticity includes changes in the organization of sensorimotor cortex and in neuronal firing patterns
that carry information about sensory and motor events. The combined Bethea and Moxon labs have
extensive experience measuring and manipulating glial and neuronal plasticity after spinal cord injury. By
combining expertise, we can address, for the first time, how these two systems, neuronal and glial, interact
to promote functional recovery. We will compare results from a series of 9 Experiments in animals with a
complete spinal transection to those with a severe spinal contusion. These Experiments will assess
electrophysiology changes (Experiments 1-4), the effect of lesioning the reorganized cortex (Experiment 5)
and trace the source of this reorganization (Experiment 6). In Experiment 7, the impact of therapy on
differences in spared fibers that cross the lesion will be measured. Finally, difference in the proteins/
genes associated with neuroplasticity and inflammation in the brains of animals will be compared
between transected and contused animals (Experiments 8 and 9).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TNFR2 Sex Differences and EAE
-
批准号:10384115
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2021
-
负责人:John Roland Bethea
-
依托单位:
TNFR2 Sex Differences and EAE
-
批准号:10532717
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2021
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10207806
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10019418
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10441446
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
SCI-induced deficits in antiviral immunity: The role of sTNF.
-
批准号:10657427
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2019
-
负责人:John Roland Bethea
-
依托单位:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
-
批准号:10386794
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2018
-
负责人:John Roland Bethea
-
依托单位:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
-
批准号:9902562
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2018
-
负责人:John Roland Bethea
-
依托单位:
Enhancing supraspinal plasticity to improve functional recovery after SCI
-
批准号:9976601
-
项目类别:
-
资助金额:$59.57万
-
财政年份:2017
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8824782
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8063946
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8462700
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:7743678
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
Astrocytes Play a Critical Role in the Pathology of EAE
-
批准号:8259198
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:6914116
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF--kB in SCI
-
批准号:8460533
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7176070
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7566013
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF-kB in SCI
-
批准号:7017095
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
The Role of Astroglial-NF--kB in SCI
-
批准号:8662321
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2005
-
负责人:John Roland Bethea
-
依托单位:
海外基金